Atlas Trials

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents

Clinical trial NCT04992208 · COMPLETED

Trial details

NCT number
NCT04992208
Sponsor
Sinovac Life Sciences Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19
Start date
2021-07-24
Primary completion
2023-03-24
Enrollment
31041

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.